Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PLC Systems

This article was originally published in The Gray Sheet

Executive Summary

Proposed offering should enable the firm to meet cash requirements through the end of 1993. The Milford, Massachusetts-based company plans to use the $1.4 mil. in expected net proceeds for costs associated with premarket approval of its Heart Laser, a laser system for transmyocardial revascularization ("The Gray Sheet" June 22, 1992, p. 17). Of the 850,534 shares registered on Feb. 12 with the Securities and Exchange Commission, 765,844 will be offered by stockholders. The remaining 84,699 shares are issuable upon the exercise of warrants granted in an August 1992 bridge financing. The estimated $1.4 mil. in proceeds will be realized via the exercise of the warrants and upon payment of promissory notes that were issued in connection with the warrants.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts